The report also profiles the twelve most active genetic testing market players worldwide: Abbott Laboratories, Roche Diagnostics, Myriad Genetics, Life Technologies, Genomic Health, Sequenom, Transgenomic, Dako, Gen-Probe, Quest Diagnostics, Genoptix ...

The past year also witnessed significant M&A deals, including the acquisition of Switzerland-based Synthes Inc. by Johnson & Johnson (JNJ) for a whopping $19.7 billion, and Gen-Probe Inc. by Hologic (HOLX) for $3.8 billion. Trends over the recent past ...

... Center of Excellence Hologic | Gen-Probe -- Will Waddell, Sr. Vice President, Chief Financial Officer, OncoMed Pharmaceuticals, Inc. -- Robert Williamson, Founder, LaSalle Venture Advisers, Former Director, Pharmasset -- Troy Wilson, President and ...

... Fisher Scientific Inc., Immucor, Inc., BioPorto Diagnostics A/S, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Qiagen N.V.

Hologic, which focuses on products for women's health, in August completed its roughly $3.8 billion acquisition of test-maker Gen-Probe Inc., expanding its offerings to include products for diagnosing sexually transmitted diseases. "The fundamental ...

Herman Rosenman: Mr. Rosenman was most recently at Gen-Probe Inc., a medical diagnostics company, where starting in 2001 he held the role of SVP of Finance and Chief Financial Officer.

... Atlas Medical, Thermo Fisher Scientific Inc., Abbott Laboratories, Qiagen N.V., Bio-Rad Laboratories, Inc., Cepheid, Gen-Probe Incorporated, Innogenetics NV, Nuclear Laser Medicine srl, bioMerieux S.A., Horiba, Ltd., Immucor, Inc., Diagnostica ...

The Corporation has also granted a worldwide exclusive license to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. operating as Hologic Gen-Probe, for the development and commercialization of a prostate cancer test using PCA3, DiagnoCure's ...

Herman Rosenman: Mr. Rosenman was most recently at Gen-Probe Inc., a medical diagnostics company, where starting in 2001 he held the role of SVP of Finance and Chief Financial Officer.

"We are rapidly approaching the national conference and have a great lineup of industry leaders who will be discussing a number of topics that are of interest to financial leaders," said Brandi Roberts, Chief Financial Officer of Mast Therapeutics, Inc ...